TCL Archive Drug Development: FDA Grants Breakthrough Therapy Designation to CTL019 In ALL July 11, 2014
TCL Archive Charles Balch resigns as ASCO executive vice president; Joseph Bailes named interim EVP. October 28, 2005
TCL Archive Rauscher, ACS Oppose Kennedy Bill, Defend NCI Special Authority, Say Funding Level Inadequate May 11, 1979